HCW BIOLOGICS INC's ticker is and the CUSIP is 40423R105. A total of 14 filers reported holding HCW BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,900 | -12.4% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $2,170 | +54.9% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $1,401 | -26.8% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,915 | -4.2% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 72,600 | $160,000 | 0.00% |
| HighTower Advisors, LLC | 225,598 | $495,000 | 0.00% |
| Focused Wealth Management, Inc | 1,000 | $2,000 | 0.00% |
| UBS Group AG | 2,056 | $5,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 39,700 | $87,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 48 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 55,425 | $121,000 | 0.00% |
| STATE STREET CORP | 21,446 | $47,000 | 0.00% |
| MORGAN STANLEY | 500 | $1,000 | 0.00% |